// STATE LEGISLATION TRACKER

Florida HB 1407: Compounding Pharmacies

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Florida
Bill: HB 1407
Session: 2026
Filed: 2025-02-27
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Florida HB1407 is a civil-rights procedure law about deadlines for filing employment discrimination lawsuits and how the Florida Commission on Human Relations sends notices. Based on the title, subjects, and available summaries, it does not regulate peptides, prescribing, telehealth, compounding, controlled substances, or prescription monitoring.

Key Points

No direct change to compounded peptide access
No change to off-label prescribing rules
No change to telehealth prescribing pathways
No change to NP or naturopathic scope
No change to FDA 503A or 503B compounding

What to Watch For

Note Clinics should know this affects civil-rights lawsuit timing, not medical prescribing or pharmacy practice.

Note Employment discrimination claims tied to clinic workplaces may have clearer filing deadlines.

Note The law takes effect July 1, 2026, but it does not create a peptide-specific compliance duty.

Where the Bill Stands

The bill was approved by the Governor on May 22, 2026 and assigned Chapter No. 2026-116 on May 26, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws